The chip giant says Vera Rubin will sharply cut the cost of training and running AI models, strengthening the appeal of its integrated computing platform.
The U.S. no longer broadly recommends vaccines for flu, hepatitis A, rotavirus and meningococcal disease. Health officials say the guidance aligns with that of peer countries.